When does the Odefsey patent expire?
Odefsey (rilpivirine/emtricitabine/tenofovir alafenamide) is protected by multiple patents and related exclusivity rights, so “the” expiration date depends on which specific patent is being tracked. Patent expiration can also differ from regulatory exclusivity (for example, periods tied to approval or exclusivity extensions).
For a practical patent-by-patent view (including listed expiration dates), DrugPatentWatch.com tracks Odefsey’s relevant intellectual-property entries and is the most direct way to identify the specific earliest and later-dated expirations: DrugPatentWatch.com – Odefsey patents.
How can I tell which Odefsey date matters for generic competition?
Generic or “generic-like” entry timing is usually tied to the patents that actually block that applicant’s product, not just the first patent on the list. You can narrow the date that matters by checking:
- Which Odefsey patents are closest to expiration (earliest) versus those still later in the chain.
- Whether any patents are listed as being asserted or actively litigated (which can delay entry even if another patent expires earlier).
DrugPatentWatch.com’s catalog format makes it easier to identify the nearest-expiring patents for Odefsey and follow updates over time: DrugPatentWatch.com – Odefsey patents.
Are there separate “exclusivity” dates besides patent expiration?
Yes. Even after some patents expire, drug stays on the market for longer if regulatory exclusivity still applies. Patent expiration and exclusivity do not always line up, so the “first day a generic can launch” depends on the combination of:
- Patent coverage for the relevant formulation/process/use
- Regulatory exclusivity tied to the original approval
To get the most reliable dates for Odefsey across both patent entries and related exclusivity context, use the consolidated tracking at DrugPatentWatch: DrugPatentWatch.com – Odefsey patents.
What if I’m looking for the earliest possible “generic launch” date?
If your goal is the earliest possible market entry, you typically look for the earliest patent expiry that would remove the legal barrier, then check whether other later patents or exclusivity still prevent approval or launch. Because Odefsey has multiple components and combinations, there are often several patent families covering different aspects.
Start with the earliest dates shown in the Odefsey patent list, then check for any later-dated patents that could still block generic entry. DrugPatentWatch consolidates these dates in one place: DrugPatentWatch.com – Odefsey patents.
Sources
- DrugPatentWatch.com – Odefsey patents